Turning complex biomedical data into actionable insights that accelerate discovery and impact.
>
Services
Delivering tailored analytics and AI solutions that turn scientific data into decisions.
>
Development journey
We follow your biology from early discovery to clinical phases and post-marketing.
>
Discover
Bio|Verse®
5
About us
Join a biology-driven data science team shaping innovation across pharma and biotech.
>
Careers
Join a biology-driven data science team shaping innovation across pharma and biotech.
>
Case studies
News
Blogs
Let’s discuss how we can turn your data into real scientific impact.
Contact us >
Dialog window
Development journey
Services
Bio|Verse®
Case studies
About
Careers
News
Blogs
Let’s discuss how we can turn your data into real scientific impact.
Contact us >
BioLizard hosts Bits in Bio Belgium meeting
BioLizard hosted the Bits in Bio Belgium meeting, bringing together 50+ attendees to explore AI and machine learning in life sciences. Talks highlighted data governance, pipeline optimization, and interactive ML tools, fostering networking and collaboration across the scientific community.
Ghent, 24th June 2023.
What do you see in this photo?
It’s a community of people from a range of different backgrounds who all share a common interest: using the power of tech to advance science!
On June 23rd 2023, BioLizard hosted a Bits in Bio Belgium meeting, which drew over fifty attendees to listen in to a series of three talks – with a healthy dose of networking and pizza on the side.
Jasper Zuallaert of VIB kicked off the event with a talk on Phospholingo, and left us with the take-home message that it’s key to know your data intimately before applying machine learning tools to it.
Next, Alexander Koch, our Team Lead Bioinformatics & Senior Bioinformatics Scientist, took the stage to highlight the importance of effective data governance and architecture in making biological research truly data driven. Alexander also presented a case study about using AI to streamline drug development pipelines, including an example of how to make machine learning output interactive and easy to interpret for wet lab scientists.
Are you ready to harness the power of language models and machine learning in your life sciences company? We have deep biological knowledge combined with a proven track record in using AI to turn biological data into value, and we’re ready to support you! Reach out to BioLizard today to get started.
Oncology drug development often begins in patients, allowing early safety and efficacy insights. Yet many cancer drugs still fail in the clinic. We validate the target but ignore its context within the tumor microenvironment. This article explores why spatial biology may improve clinical success.
BioLizard has been named “Bioinformatics Innovation of the Year” in the 2025 BioTech Breakthrough Awards. The honor spotlights Bio|Verse® Navigator, a visual analytics workspace that unifies complex R&D data so scientists can decide faster, with confidence.
Bioinformatics pipelines break for the smallest reasons: package updates, shifting dependencies, or “it only works on my machine.” This post explains why experienced software engineers and DevOps practices (Git, CI/CD, IaC) are essential to keep workflows reproducible, stable, and scalable.